Delirium resolving upon switching from risperidone to quetiapine: Implication of CYP2D6 genotype [2]

Psychosomatics

Volumn 46, Issue 4, 2005, Pages 374-375

  Kalo, Daiji ^a   Kawanishi, Chiaki ^a   Kishida, Ikuko ^a   Furuno, Taku ^a   Matsumura, Takehiko ^a   Hasegawa, Hana ^a   Hirayasu, Yoshio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CYTOCHROME P450 2D6; QUETIAPINE; RISPERIDONE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

AGED; ALZHEIMER DISEASE; CASE REPORT; DELIRIUM; DRUG METABOLISM; DRUG SAFETY; DYSARTHRIA; DYSPHAGIA; DYSTONIA; ENZYME ACTIVITY; EXTRAPYRAMIDAL SYMPTOM; GENOTYPE; GERIATRIC PATIENT; HUMAN; LETTER; MALE; MUSCLE RIGIDITY; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME; TREMOR; CHEMICALLY INDUCED DISORDER; GENETICS;

AGED; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CYTOCHROME P-450 CYP2D6; DELIRIUM; DIBENZOTHIAZEPINES; GENOTYPE; HUMANS; MALE; RISPERIDONE;

EID: 24044451604     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.46.4.374     Document Type: Letter

References (6)

1. Bertilsson L, Dahl ML, Dalen P, Al-Shurbaji A: Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol 2002; 53:111-122
2. American Psychiatric Association: Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999; 156(suppl5):1-20
3. Schwanz TL, Masand PS: The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 2002; 43:171-174
4. Spina E, Scordo MG, D'Arrigo C: Metabolic drug interactions with new psychotropic agents. Fundam Clin Pharmacol 2003; 17:517-538
5. Mihara K, Kondo T, Yasui-Furukori N, Suzuki A, Ishida M, Ono S, Kubota T, Iga T, Takarada Y, de Vries R, Kaneko S: Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia. Ther Drug Monit 2003; 25:287-293
6. Spina E, Avenoso A, Facciola G, Salemi M, Scordo MG, Ancione M, Madia AG, Perucca E: Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia. Psychopharmacology (Berl) 2001; 153:238-243